Correlated analysis and pathological study on insulin resistance and cardiovascular endocrine hormone in elderly

Hua Zhi1, Hongbin Wang1, Tao Li1

  • 1Department of Cardiology, Affiliated Hospital of Hebei Engineering University, PR China.

Insights

Insulin resistance is linked to cardiovascular endocrine hormones in elderly hypertension patients. This study reveals a significant correlation, highlighting its role in hypertension development.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Geriatrics

Background:

  • Elderly hypertension is a significant health concern.
  • Insulin resistance is increasingly recognized as a factor in cardiovascular disease.
  • Cardiovascular endocrine hormones play a crucial role in blood pressure regulation.

Purpose of the Study:

  • To investigate the correlation between insulin resistance and cardiovascular endocrine hormones in elderly hypertension patients.
  • To conduct a pathological study on the interplay of these factors.
  • To understand the role of insulin resistance and hormone levels in the development of hypertension.

Main Methods:

  • A clinical observation and experimental study involving 300 subjects (150 hypertension patients, 150 healthy controls).
  • Measurement of serum levels and activity of tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI), atrial natriuretic peptide (ANP), insulin sensitivity (IS), and endothelin (ET).
  • Correlated analysis of insulin resistance markers and cardiovascular endocrine hormones in relation to hypertension status.

Main Results:

  • Hypertension patients showed significantly higher levels of PAI, ANP, and ET compared to controls (p<0.05).
  • Hypertensive individuals exhibited significantly lower levels of t-PA and IS than healthy controls (p>0.05).
  • A significant correlation and pathological effect were observed between insulin resistance and cardiovascular endocrine hormones in hypertensive patients.

Conclusions:

  • Insulin resistance and cardiovascular endocrine hormones are significantly correlated in elderly hypertensive patients.
  • These factors play a crucial role in the genesis and development of hypertension in the elderly.
  • The findings suggest potential therapeutic targets for managing hypertension in this population.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
773
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K